Biotech & AI drug discoverySTAT — Biotech

STAT+: Five biotech updates to read after ESMO this weekend

STAT+ rounds up five biotech updates to read after this weekend's ESMO meeting. Among them, Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, which Moderna CEO Stéphane Bancel says is expected in 2027.

AI summary · generated only from source feed metadata; consult original

Source published2026-10-26T13:38:56+00:00

Published here2026-10-26T14:01:23+00:00

Original source

STAT — Biotech

Media report · consult original reporting

Read the original ↗https://www.statnews.com/2026/10/26/biotech-news-moderna-ceo-on-whats-next-after-intismeran-success/

Original headline

STAT+: Five biotech updates to read after ESMO this weekend

AI bilingual edit · consult original

Headlines are indexed or machine translated, not independent verification of scientific results. Medical news is not clinical advice. Distinguish interstellar concepts from demonstrated space technology using the original source.